Caris Life Sciences, Inc. (CAI)
19.53
-1.32
(-6.33%)
USD |
NASDAQ |
Feb 20, 16:00
19.52
-0.01
(-0.05%)
After-Hours: 20:00
Caris Life Sciences Market Cap : 5.510B for Feb. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Neurocrine Biosciences, Inc. | 12.91B |
| Glaukos Corp. | 6.908B |
| Edgewise Therapeutics, Inc. | 3.103B |
| Nuvalent, Inc. | 7.307B |
| Alphatec Holdings, Inc. | 1.933B |
Market Cap Related Metrics
| PS Ratio | 8.466 |
| PEG Ratio | -0.0696 |
| Price to Book Value | 11.52 |
| Price | 19.53 |
| Earnings Yield | -12.42% |
| PEGY Ratio | -0.0696 |